First Posted,NCT Number,Title,Start Date,Completion Date,Sponsor/Collaborators,Company Name
"July 20, 2020",NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors,"July 1, 2020",January 2024,Sapience Therapeutics,Sapience Therapeutics
"November 5, 2008",NCT00785057,Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke,November 2008,December 2008,AstraZeneca,Sapience Therapeutics
